News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aclaris Therapeutics Raises $21 Million in Stock Sale


9/13/2012 9:10:14 AM

Philadelphia Business Journal by John George, Senior Reporter

Aclaris Therapeutics raised $20.9 million in private stock sale this week, according to documents filed with the Securities and Exchange Commission.

The biopharmaceutical company, based in Malvern, Pa., is specializing in developing new treatments for skin disorders.

Philadelphia law firm Duane Morris served as financial adviser to Aclaris for the company’s series A venture capital financing. The identity of the investors was not disclosed.

Aclaris, established earlier this year, is led by President and CEO Neal Walker who was previously the chief executive of another local biopharmaceutical company, Vicept, which was acquired by Allergan last year in a deal valued at up to $275 million.




comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES